BSE filing, NSE: HARYNACAP. Summary written from the filing by ALFA Finder's alert engine.
Haryana Capfin Ltd: key numbers
- Share price
- ₹133.00
- Market cap
- ₹69.28 Cr
- Revenue (annual)
- ₹6.44 Cr
- Net profit (annual)
- ₹9.76 Cr
- P/E (TTM)
- 7.7×Sector 33.5×
- Promoter holding
- 70.78%+0.00% QoQ
- FII holding
- 0.81%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Haryana Capfin Ltd
All →Haryana Capfin Other Announcement
Haryana Capfin Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Haryana Capfin Annual General Meeting
Haryana Capfin Limited conducted its 28th Annual General Meeting on September 25, 2026. Shareholders considered the adoption of audited financial statements and director re-appointments.
Haryana Capfin Annual General Meeting
Haryana Capfin Limited has issued a notice for its 28th Annual General Meeting on September 25, 2026. Key agenda items include adopting financial statements and director re-appointments.
Haryana Capfin Annual Report
Haryana Capfin Limited has scheduled its 28th Annual General Meeting for September 25, 2026. The company also released its full Annual Report for the financial year 2025-26.
Haryana Capfin Q1 FY27 Results: Net Loss of ₹0.8 Cr
Haryana Capfin Ltd reported a net loss of ₹0.8 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.8 Cr
Haryana Capfin Board Meeting Date
Haryana Capfin Ltd scheduled a board meeting for August 10, 2026. The meeting will consider the unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.